|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of goods sold | |||||
| Gross profit (loss) | |||||
| Operating expenses | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Loss from write-down of property, plant and equipment | |||||
| Grant income, net | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Other (expense) income | |||||
| Interest expense, net | |||||
| Nonrelated Party | |||||
| Related Party | |||||
| Change in fair value of debt - related party | |||||
| Change in fair value of warrants | |||||
| Change in fair value of derivatives - related parties | |||||
| Change in fair value of derivatives | |||||
| Nonrelated Party | |||||
| Related Party | |||||
| (Loss) gain on debt extinguishment | |||||
| Induced conversion expense | |||||
| Other expense | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss attributable to shareholders | |||||
| Remeasurement of Preferred Stock - related party | |||||
| Down round deemed dividend | |||||
| Net loss attributable to common shareholders | |||||
| Other comprehensive loss attributable to common shareholders | |||||
| Change in fair value of debt - credit risk - related party | |||||
| Foreign currency translation adjustment | |||||
| Comprehensive loss attributable to common shareholders | |||||
| Basic and diluted loss per share attributable to common shareholders | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares of common stock | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...